Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Subst Use Misuse. 2023;58(13):1651-1659. doi: 10.1080/10826084.2023.2238301. Epub 2023 Jul 26.
Medication for Opioid Use Disorder (MOUD) is a best practice for treating individuals with opioid use disorder (OUD), and primary care-based MOUD management can reduce treatment barriers among OUD patients. Individuals with OUD experience disproportionately high rates of trauma and violence, highlighting the importance of addressing trauma, mental health, and substance use concurrently. However, clear guidelines for trauma-informed treatment in a primary care setting remain poorly established. A qualitative approach was engaged to explore primary care providers' perceptions of barriers and facilitators to assessing and treating trauma among MOUD patients. Twenty in-depth interviews were conducted in 2021 with Baltimore-based MOUD prescribers, including primary care physicians and nurse practitioners. Interview questions assessed experiences with identifying and treating trauma among MOUD patients, including challenges and opportunities. Providers reported extensive histories of trauma experienced by MOUD patients. Barriers to addressing trauma include a lack of standardized protocols/procedures for identifying trauma, insufficient training/time to assess and treat trauma, and the limited availability of external mental health providers and specialty services. Opportunities included building strong, mutually respectful patient-provider relationships, providing individualized, person-centered care, and establishing connections to coordinated multidisciplinary treatment networks. MOUD treatment within primary care is an important way to increase OUD treatment access, but clearer standards are needed for the treatment of trauma within this patient population. These findings demonstrate opportunities to improve standards and systems such that primary care providers are better equipped to assess and treat the complex histories of trauma experienced by individuals with OUD.
阿片类药物使用障碍(MOUD)药物治疗是治疗阿片类药物使用障碍(OUD)患者的最佳实践,而基于初级保健的 MOUD 管理可以减少 OUD 患者的治疗障碍。OUD 患者经历不成比例的高创伤和暴力率,这凸显了同时解决创伤、心理健康和物质使用问题的重要性。然而,在初级保健环境中进行创伤知情治疗的明确指南仍未得到很好的建立。
采用定性方法探讨初级保健提供者评估和治疗 MOUD 患者创伤的障碍和促进因素。2021 年,与巴尔的摩的 MOUD 处方者(包括初级保健医生和护士从业者)进行了 20 次深入访谈。访谈问题评估了 MOUD 患者识别和治疗创伤的经验,包括挑战和机会。
提供者报告了 MOUD 患者广泛的创伤经历。解决创伤的障碍包括缺乏识别创伤的标准化协议/程序、评估和治疗创伤的时间和资源不足,以及外部心理健康提供者和专业服务的有限可用性。机会包括建立强大、相互尊重的医患关系、提供个性化、以患者为中心的护理以及建立与协调的多学科治疗网络的联系。
在初级保健中进行 MOUD 治疗是增加 OUD 治疗机会的重要途径,但在这一患者群体中,需要更明确的创伤治疗标准。这些发现表明有机会改善标准和系统,使初级保健提供者能够更好地评估和治疗 OUD 患者经历的复杂创伤史。